Aigen Investment Management’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,388
Closed -$200K 806
2024
Q2
$200K Buy
18,388
+4,536
+33% +$55.8K 0.04% 623
2024
Q1
$194K Sell
13,852
-37,369
-73% -$486K 0.04% 553
2023
Q4
$539K Buy
51,221
+21,438
+72% +$192K 0.1% 314
2023
Q3
$272K Buy
29,783
+17,212
+137% +$154K 0.05% 553
2023
Q2
$91.4K Buy
+12,571
New +$108K 0.01% 680

Other funds holding EOLS

Aigen Investment Management's EOLS Position: Q3 2024 in Review

Aigen Investment Management sold out of Evolus (EOLS) in Q3 2024, closing a stake of 18,388 shares — an estimated $200K sold.

Aigen Investment Management first reported a position in EOLS in Q2 2023 and held it in 5 quarters. The position peaked at $539K in Q4 2023. 165 funds tracked by Wall St. Rank hold EOLS as of Q3 2024.

  • Aigen Investment Management reported no remaining Evolus position as of Q3 2024 after selling out during the quarter.
  • Aigen Investment Management sold 18,388 Evolus shares in Q3 2024, an estimated $200K.
  • Aigen Investment Management first reported a position in Evolus in Q2 2023 and held it in 5 quarters.
  • Aigen Investment Management's Evolus position peaked at $539K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Evolus as of Q3 2024.

Based on Aigen Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.